| Year |
Citation |
Score |
| 2023 |
Lin D, Chen Y, Koksal AR, Dash S, Aydin Y. Targeting ER stress/PKA/GSK-3β/β-catenin pathway as a potential novel strategy for hepatitis C virus-infected patients. Cell Communication and Signaling : Ccs. 21: 102. PMID 37158967 DOI: 10.1186/s12964-023-01081-9 |
0.511 |
|
| 2021 |
Aydin Y, Chedid M, Chava S, Danielle Williams D, Liu S, Hagedorn CH, Sumitran-Holgersson S, Reiss K, Moroz K, Lu H, Balart LA, Dash S. Retraction Note: Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture. Scientific Reports. 11: 17779. PMID 34471176 DOI: 10.1038/s41598-021-97265-9 |
0.452 |
|
| 2021 |
Prabhu R, Garry RF, Dash S. Retraction Note: Small interfering RNA targeted to stem-loop II of the 5' untranslated region effectively inhibits expression of six HCV genotypes. Virology Journal. 18: 155. PMID 34311743 DOI: 10.1186/s12985-021-01623-y |
0.375 |
|
| 2021 |
Aydin Y, Koksal AR, Reddy V, Lin D, Osman H, Heidari Z, Rhadhi SM, Wimley WC, Parsi MA, Dash S. Extracellular Vesicle Release Promotes Viral Replication during Persistent HCV Infection. Cells. 10. PMID 33922397 DOI: 10.3390/cells10050984 |
0.508 |
|
| 2021 |
Lin D, Reddy V, Osman H, Lopez A, Koksal AR, Rhadhi SM, Dash S, Aydin Y. Additional Inhibition of Wnt/β-Catenin Signaling by Metformin in DAA Treatments as a Novel Therapeutic Strategy for HCV-Infected Patients. Cells. 10. PMID 33918222 DOI: 10.3390/cells10040790 |
0.475 |
|
| 2020 |
Dash S, Aydin Y, Widmer KE, Nayak L. Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment. Journal of Hepatocellular Carcinoma. 7: 45-76. PMID 32346535 DOI: 10.2147/Jhc.S221187 |
0.608 |
|
| 2019 |
Dash S, Aydin Y, Moroz K. Chaperone-Mediated Autophagy in the Liver: Good or Bad? Cells. 8. PMID 31652893 DOI: 10.3390/Cells8111308 |
0.497 |
|
| 2019 |
Song K, Kwon H, Han C, Chen W, Zhang J, Ma W, Dash S, Gandhi CR, Wu T. YAP in Kupffer cells enhances the production of pro-inflammatory cytokines and promotes the development of non-alcoholic steatohepatitis. Hepatology (Baltimore, Md.). PMID 31610032 DOI: 10.1002/Hep.30990 |
0.312 |
|
| 2019 |
Aydin Y, Kurt R, Song K, Lin D, Osman H, Youngquist B, Scott JW, Shores NJ, Thevenot P, Cohen A, Dash S. Hepatic Stress Response in HCV Infection Promotes STAT3-Mediated Inhibition of HNF4A- Feedback Loop in Liver Fibrosis and Cancer Progression. Cancers. 11. PMID 31547152 DOI: 10.3390/Cancers11101407 |
0.598 |
|
| 2019 |
Dash S, Aydin Y, Wu T. Integrated stress response in hepatitis C promotes Nrf2-related chaperone-mediated autophagy: A novel mechanism for host-microbe survival and HCC development in liver cirrhosis. Seminars in Cell & Developmental Biology. PMID 31386899 DOI: 10.1016/J.Semcdb.2019.07.015 |
0.547 |
|
| 2018 |
Wang Y, Chen W, Han C, Zhang J, Song K, Kwon H, Dash S, Yao L, Wu T. Adult Hepatocytes Are Hedgehog-Responsive Cells in the Setting of Liver Injury: Evidence for Smoothened-Mediated Activation of NF-κB/Epidermal Growth Factor Receptor/Akt in Hepatocytes that Counteract Fas-Induced Apoptosis. The American Journal of Pathology. 188: 2605-2616. PMID 30366594 DOI: 10.1016/J.Ajpath.2018.07.018 |
0.329 |
|
| 2018 |
Aydin Y, Stephens CM, Chava S, Heidari Z, Panigrahi R, Danielle Williams D, Wiltz K, Bell A, Wilson W, Reiss K, Dash S. Chaperone-Mediated Autophagy Promotes Beclin1 Degradation in Persistently Infected Hepatitis C Virus (HCV) Cell Culture. The American Journal of Pathology. PMID 30075149 DOI: 10.1016/J.Ajpath.2018.06.022 |
0.472 |
|
| 2017 |
Aydin Y, Chatterjee A, Chandra PK, Chava S, Chen W, Tandon A, Dash A, Chedid M, Moehlen MW, Regenstein F, Balart LA, Cohen A, Lu H, Wu T, Dash S. Interferon-alpha-induced hepatitis C virus clearance restores p53 tumor suppressor more than direct-acting antivirals. Hepatology Communications. 1: 256-269. PMID 29404458 DOI: 10.1002/hep4.1025 |
0.531 |
|
| 2017 |
Aydin Y, Chedid M, Chava S, Danielle Williams D, Liu S, Hagedorn CH, Sumitran-Holgersson S, Reiss K, Moroz K, Lu H, Balart LA, Dash S. Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture. Scientific Reports. 7: 9223. PMID 28835697 DOI: 10.1038/S41598-017-10087-6 |
0.6 |
|
| 2017 |
Chava S, Lee C, Aydin Y, Chandra PK, Dash A, Chedid M, Thung SN, Moroz K, Wu T, Nayak NC, Dash S. Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma. Oncotarget. PMID 28402954 DOI: 10.18632/Oncotarget.16685 |
0.316 |
|
| 2016 |
Dash S, Chava S, Aydin Y, Chandra PK, Ferraris P, Chen W, Balart LA, Wu T, Garry RF. Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress Response. Viruses. 8. PMID 27223299 DOI: 10.3390/V8050150 |
0.628 |
|
| 2016 |
Dash S, Chava S, Chandra PK, Aydin Y, Balart LA, Wu T. Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response. Hepatic Medicine : Evidence and Research. 8: 9-20. PMID 26955295 DOI: 10.2147/Hmer.S63700 |
0.344 |
|
| 2016 |
Ferraris P, Chandra PK, Panigrahi R, Aboulnasr F, Chava S, Kurt R, Pawlotsky JM, Wilkens L, Osterlund P, Hartmann R, Balart LA, Wu T, Dash S. Cellular Mechanism for Impaired Hepatitis C Virus Clearance by Interferon Associated with IFNL3 Gene Polymorphisms Relates to Intrahepatic Interferon-λ Expression. The American Journal of Pathology. PMID 26896692 DOI: 10.1016/J.Ajpath.2015.11.027 |
0.597 |
|
| 2015 |
Aboulnasr F, Hazari S, Nayak S, Chandra PK, Panigrahi R, Ferraris P, Chava S, Kurt R, Song K, Dash A, Balart LA, Garry RF, Wu T, Dash S. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System. Plos One. 10: e0141655. PMID 26657215 DOI: 10.1371/Journal.Pone.0141655 |
0.636 |
|
| 2015 |
Kwon H, Song K, Han C, Chen W, Wang Y, Dash S, Lim K, Wu T. Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease (NAFLD). Hepatology (Baltimore, Md.). PMID 26473743 DOI: 10.1002/Hep.28289 |
0.381 |
|
| 2015 |
Panigrahi R, Dash S. ENT1 and treatment of viral diseases. Oncotarget. 6: 32281-2. PMID 26431496 DOI: 10.18632/Oncotarget.5859 |
0.419 |
|
| 2015 |
Kurt R, Chandra PK, Aboulnasr F, Panigrahi R, Ferraris P, Aydin Y, Reiss K, Wu T, Balart LA, Dash S. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture. Plos One. 10: e0125962. PMID 25961570 DOI: 10.1371/Journal.Pone.0125962 |
0.657 |
|
| 2015 |
Song K, Han C, Dash S, Balart LA, Wu T. MiR-122 in hepatitis B virus and hepatitis C virus dual infection. World Journal of Hepatology. 7: 498-506. PMID 25848473 DOI: 10.4254/Wjh.V7.I3.498 |
0.529 |
|
| 2015 |
Panigrahi R, Chandra PK, Ferraris P, Kurt R, Song K, Garry RF, Reiss K, Coe IR, Furihata T, Balart LA, Wu T, Dash S. Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1. Journal of Virology. 89: 626-42. PMID 25339775 DOI: 10.1128/Jvi.02492-14 |
0.652 |
|
| 2014 |
Chandra PK, Gunduz F, Hazari S, Kurt R, Panigrahi R, Poat B, Bruce D, Cohen AJ, Bohorquez HE, Behorquez HE, Carmody I, Loss G, Balart LA, Wu T, Dash S. Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis. Plos One. 9: e108616. PMID 25265476 DOI: 10.1371/Journal.Pone.0108616 |
0.81 |
|
| 2014 |
Sabahi A, Uprichard SL, Wimley WC, Dash S, Garry RF. Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain. Journal of Virology. 88: 10280-8. PMID 24991010 DOI: 10.1128/Jvi.00874-14 |
0.585 |
|
| 2014 |
Bao L, Chandra PK, Moroz K, Zhang X, Thung SN, Wu T, Dash S. Impaired autophagy response in human hepatocellular carcinoma. Experimental and Molecular Pathology. 96: 149-54. PMID 24369267 DOI: 10.1016/J.Yexmp.2013.12.002 |
0.344 |
|
| 2014 |
Chandra PK, Bao L, Song K, Aboulnasr FM, Baker DP, Shores N, Wimley WC, Liu S, Hagedorn CH, Fuchs SY, Wu T, Balart LA, Dash S. HCV infection selectively impairs type I but not type III IFN signaling. The American Journal of Pathology. 184: 214-29. PMID 24215913 DOI: 10.1016/J.Ajpath.2013.10.005 |
0.649 |
|
| 2014 |
Gunduz F, Mallikarjun C, Balart LA, Dash S. Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infection. Experimental and Molecular Pathology. 96: 36-41. PMID 24211829 DOI: 10.1016/J.Yexmp.2013.10.016 |
0.656 |
|
| 2013 |
Panigrahi R, Hazari S, Chandra S, Chandra PK, Datta S, Kurt R, Cameron CE, Huang Z, Zhang H, Garry RF, Balart LA, Dash S. Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation. Plos One. 8: e72791. PMID 24009705 DOI: 10.1371/Journal.Pone.0072791 |
0.657 |
|
| 2013 |
Song K, Han C, Zhang J, Lu D, Dash S, Feitelson M, Lim K, Wu T. Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells. Hepatology (Baltimore, Md.). 58: 1681-92. PMID 23703729 DOI: 10.1002/Hep.26514 |
0.401 |
|
| 2012 |
Gunduz F, Aboulnasr FM, Chandra PK, Hazari S, Poat B, Baker DP, Balart LA, Dash S. Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture. Virology Journal. 9: 143. PMID 22863531 DOI: 10.1186/1743-422X-9-143 |
0.807 |
|
| 2012 |
Chandra PK, Kundu AK, Hazari S, Chandra S, Bao L, Ooms T, Morris GF, Wu T, Mandal TK, Dash S. Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1724-36. PMID 22617108 DOI: 10.1038/Mt.2012.107 |
0.653 |
|
| 2012 |
Kundu AK, Chandra PK, Hazari S, Ledet G, Pramar YV, Dash S, Mandal TK. Stability of lyophilized siRNA nanosome formulations. International Journal of Pharmaceutics. 423: 525-34. PMID 22172291 DOI: 10.1016/J.Ijpharm.2011.11.040 |
0.409 |
|
| 2012 |
Kundu AK, Chandra PK, Hazari S, Pramar YV, Dash S, Mandal TK. Development and optimization of nanosomal formulations for siRNA delivery to the liver. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fã¼R Pharmazeutische Verfahrenstechnik E.V. 80: 257-67. PMID 22119665 DOI: 10.1016/J.Ejpb.2011.10.023 |
0.462 |
|
| 2011 |
Datta S, Hazari S, Chandra PK, Samara M, Poat B, Gunduz F, Wimley WC, Hauser H, Koster M, Lamaze C, Balart LA, Garry RF, Dash S. Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1. Virology Journal. 8: 351. PMID 21756311 DOI: 10.1186/1743-422X-8-351 |
0.814 |
|
| 2011 |
Hazari S, Hefler HJ, Chandra PK, Poat B, Gunduz F, Ooms T, Wu T, Balart LA, Dash S. Hepatocellular carcinoma xenograft supports HCV replication: a mouse model for evaluating antivirals. World Journal of Gastroenterology : Wjg. 17: 300-12. PMID 21253388 DOI: 10.3748/Wjg.V17.I3.300 |
0.808 |
|
| 2010 |
Poat B, Hazari S, Chandra PK, Gunduz F, Balart LA, Alvarez X, Dash S. SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells. Plos One. 5. PMID 20949125 DOI: 10.1371/Journal.Pone.0013117 |
0.785 |
|
| 2010 |
Poat B, Hazari S, Chandra PK, Gunduz F, Alvarez X, Balart LA, Garry RF, Dash S. Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication. Virology Journal. 7: 265. PMID 20939906 DOI: 10.1186/1743-422X-7-265 |
0.789 |
|
| 2010 |
Raychoudhuri A, Shrivastava S, Steele R, Dash S, Kanda T, Ray R, Ray RB. Hepatitis C virus infection impairs IRF-7 translocation and Alpha interferon synthesis in immortalized human hepatocytes. Journal of Virology. 84: 10991-8. PMID 20810735 DOI: 10.1128/Jvi.00900-10 |
0.642 |
|
| 2010 |
Chandra PK, Hazari S, Poat B, Gunduz F, Prabhu R, Liu G, Burioni R, Clementi M, Garry RF, Dash S. Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone. Virology Journal. 7: 118. PMID 20529250 DOI: 10.1186/1743-422X-7-118 |
0.8 |
|
| 2010 |
Hazari S, Chandra PK, Poat B, Datta S, Garry RF, Foster TP, Kousoulas G, Wakita T, Dash S. Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway. Virology Journal. 7: 36. PMID 20149251 DOI: 10.1186/1743-422X-7-36 |
0.818 |
|
| 2007 |
Hazari S, Taylor L, Haque S, Garry RF, Florman S, Luftig R, Regenstein F, Dash S. Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon. Virology Journal. 4: 89. PMID 17877826 DOI: 10.1186/1743-422X-4-89 |
0.548 |
|
| 2006 |
Prabhu R, Garry RF, Dash S. Small interfering RNA targeted to stem-loop II of the 5' untranslated region effectively inhibits expression of six HCV genotypes. Virology Journal. 3: 100. PMID 17129382 DOI: 10.1186/1743-422X-3-100 |
0.58 |
|
| 2005 |
Dash S, Haque S, Joshi V, Prabhu R, Hazari S, Fermin C, Garry R. HCV-hepatocellular carcinoma: new findings and hope for effective treatment. Microscopy Research and Technique. 68: 130-48. PMID 16276514 DOI: 10.1002/Jemt.20227 |
0.649 |
|
| 2005 |
Hazari S, Patil A, Joshi V, Sullivan DE, Fermin CD, Garry RF, Elliott RM, Dash S. Alpha interferon inhibits translation mediated by the internal ribosome entry site of six different hepatitis C virus genotypes. The Journal of General Virology. 86: 3047-53. PMID 16227227 DOI: 10.1099/Vir.0.81132-0 |
0.627 |
|
| 2005 |
Prabhu R, Vittal P, Yin Q, Flemington E, Garry R, Robichaux WH, Dash S. Small interfering RNA effectively inhibits protein expression and negative strand RNA synthesis from a full-length hepatitis C virus clone. Journal of Medical Virology. 76: 511-9. PMID 15977238 DOI: 10.1002/Jmv.20391 |
0.604 |
|
| 2005 |
Pai M, Prabhu R, Panebra A, Nangle S, Haque S, Bastian F, Garry R, Agrawal K, Goodbourn S, Dash S. Activation of interferon-stimulated response element in huh-7 cells replicating hepatitis C virus subgenomic RNA. Intervirology. 48: 301-11. PMID 15956798 DOI: 10.1159/000085099 |
0.618 |
|
| 2005 |
Dash S, Prabhu R, Hazari S, Bastian F, Garry R, Zou W, Haque S, Joshi V, Regenstein FG, Thung SN. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation. Liver International : Official Journal of the International Association For the Study of the Liver. 25: 580-94. PMID 15910496 DOI: 10.1111/J.1478-3231.2005.01082.X |
0.629 |
|
| 2004 |
Prabhu R, Khalap N, Burioni R, Clementi M, Garry RF, Dash S. Inhibition of hepatitis C virus nonstructural protein, helicase activity, and viral replication by a recombinant human antibody clone. The American Journal of Pathology. 165: 1163-73. PMID 15466383 DOI: 10.1016/S0002-9440(10)63377-9 |
0.595 |
|
| 2004 |
Prabhu R, Joshi V, Garry RF, Bastian F, Haque S, Regenstein F, Thung S, Dash S. Interferon alpha-2b inhibits negative-strand RNA and protein expression from full-length HCV1a infectious clone. Experimental and Molecular Pathology. 76: 242-52. PMID 15126107 DOI: 10.1016/J.Yexmp.2004.01.004 |
0.525 |
|
| 2003 |
Garry RF, Dash S. Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins. Virology. 307: 255-65. PMID 12667795 DOI: 10.1016/S0042-6822(02)00065-X |
0.461 |
|
| 2003 |
Akhter S, Liu H, Prabhu R, DeLucca C, Bastian F, Garry RF, Schwartz M, Thung SN, Dash S. Epstein-Barr virus and human hepatocellular carcinoma. Cancer Letters. 192: 49-57. PMID 12637152 DOI: 10.1016/S0304-3835(02)00695-X |
0.547 |
|
| 2003 |
Qi ZT, Kalkeri G, Hanible J, Prabhu R, Bastian F, Garry RF, Dash S. Stem-loop structures II-IV of the 5' untranslated sequences are required for the expression of the full-length hepatitis C virus genome. Archives of Virology. 148: 449-467. PMID 12607098 DOI: 10.1007/S00705-002-0933-0 |
0.571 |
|
| 2003 |
Panebra A, Shah K, Prabhu R, Bastian F, Garry RF, Joshi V, Haque S, Regenstein FG, Goodbourn S, Dash S. 990 Hepatitis C virus genomic and sub-genomic clones activate interferon-stimulated response element in HUH-7 cells Hepatology. 38: 633-633. DOI: 10.1016/S0270-9139(03)81028-5 |
0.43 |
|
| 2003 |
Panebra A, Shah K, Prabhu R, Bastian F, Garry RF, Joshi V, Haque S, Regenstein FG, Elliott R, Dash S. 974 IFN-A 2B inhibits internal ribosome entry site mediated translation of green fluorescence protein from six different HCV genotypes Hepatology. 38: 625-625. DOI: 10.1016/S0270-9139(03)81012-1 |
0.528 |
|
| 2003 |
Nangle S, Prahbu R, Dash S, Garry RF. 393 Effects of HIV tat on hepatitis C virus replication Hepatology. 38: 349-349. DOI: 10.1016/S0270-9139(03)80436-6 |
0.401 |
|
| 2003 |
Prabhu R, Vital P, Erik F, Garry RF, Bastian F, Dash S. 133 Development of small interfering RNA (SIRNAS) against full-length hepatitis C virus 1A strain Hepatology. 38: 220-220. DOI: 10.1016/S0270-9139(03)80176-3 |
0.398 |
|
| 2002 |
Sullivan DE, Mondelli MU, Curiel DT, Krasnykh V, Mikheeva G, Gaglio P, Morris CB, Dash S, Gerber MA. Construction and characterization of an intracellular single-chain human antibody to hepatitis C virus non-structural 3 protein. Journal of Hepatology. 37: 660-8. PMID 12399234 DOI: 10.1016/S0168-8278(02)00270-2 |
0.581 |
|
| 2001 |
Kalkeri G, Khalap N, Akhter S, Garry RF, Fermin CD, Dash S. Hepatitis C viral proteins affect cell viability and membrane permeability. Experimental and Molecular Pathology. 71: 194-208. PMID 11733945 DOI: 10.1006/Exmp.2001.2392 |
0.62 |
|
| 2001 |
Dash S, Kalkeri G, McClure HM, Garry RF, Clejan S, Thung SN, Murthy KK. Transmission of HCV to a chimpanzee using virus particles produced in an RNA-transfected HepG2 cell culture. Journal of Medical Virology. 65: 276-281. PMID 11536233 DOI: 10.1002/Jmv.2030 |
0.602 |
|
| 2001 |
Myung J, Khalap N, Kalkeri G, Garry R, Dash S. Inducible model to study negative strand RNA synthesis and assembly of hepatitis C virus from a full-length cDNA clone. Journal of Virological Methods. 94: 55-67. PMID 11337040 DOI: 10.1016/S0166-0934(01)00278-6 |
0.621 |
|
| 2001 |
Kalkeri G, Khalap N, Garry RF, Fermin CD, Dash S. Hepatitis C virus protein expression induces apoptosis in HepG2 cells. Virology. 282: 26-37. PMID 11259187 DOI: 10.1006/Viro.2000.0835 |
0.591 |
|
| 2001 |
Burioni R, Khalap N, Kalkeri G, Clementi M, Dash S. Inhibition of HCV-NS3 helicase activity and negative strand rna syntesis by intracellular expression of a recombinant human anti-NS3 Fab Journal of Hepatology. 34: 222. DOI: 10.1016/S0168-8278(01)81700-1 |
0.525 |
|
| 2000 |
Dash S, Saxena R, Myung J, Rege T, Tsuji H, Gaglio P, Garry RF, Thung SN, Gerber MA. HCV RNA levels in hepatocellular carcinomas and adjacent non-tumorous livers. Journal of Virological Methods. 90: 15-23. PMID 11011077 DOI: 10.1016/S0166-0934(00)00199-3 |
0.556 |
|
| 2000 |
Karavattathayyil SJ, Kalkeri G, Liu H, Gaglio P, Garry RF, Krause JR, Dash S. Detection of hepatitis C virus RNA sequences in B-cell non-Hodgkin lymphoma. American Journal of Clinical Pathology. 113: 391-398. PMID 10705820 DOI: 10.1309/Rev9-Fdtm-5Ngc-Hbwy |
0.579 |
|
| 2000 |
Myung JS, Garry RF, Dash S. Replication of a chimpanzee infectious clone for HCV in cell culture using a replication defective adenovirus that expresses T7 RNA polymerase Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)85979-X |
0.519 |
|
| 1999 |
Halim A, Garry RF, Dash S, Gerber MA. Effect of schistosomiasis and hepatitis on liver disease. American Journal of Tropical Medicine and Hygiene. 60: 915-920. PMID 10403320 DOI: 10.4269/Ajtmh.1999.60.915 |
0.578 |
|
| 1997 |
Hiramatsu N, Dash S, Gerber MA. HCV cDNA transfection to HepG2 cells Journal of Viral Hepatitis. 4: 61-67. PMID 9097280 DOI: 10.1111/J.1365-2893.1997.Tb00162.X |
0.63 |
|
| 1997 |
Sullivan DE, Dash S, Du H, Hiramatsu N, Aydin F, Kolls J, Blanchard J, Baskin G, Gerber MA. Liver-Directed Gene Transfer in Non-Human Primates Human Gene Therapy. 8: 1195-1206. DOI: 10.1089/Hum.1997.8.10-1195 |
0.306 |
|
| 1995 |
Hytiroglou P, Dash S, Haruna Y, Fernandez M, Theise ND, Schwartz M, Miller C, Bodenheimer HC, Thung SN, Gerber MA. Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology. American Journal of Clinical Pathology. 104: 588-593. PMID 7572821 DOI: 10.1093/Ajcp/104.5.588 |
0.576 |
|
| 1995 |
Lei D, Wu J, Sullivan DE, Dash S, Gerber MA. Detection of hepatitis B virus sequences in liver tissues of seronegative organ donors International Hepatology Communications. 3: 154-160. DOI: 10.1016/0928-4346(94)00173-3 |
0.362 |
|
| 1994 |
Chu H, Dash S, Gerber MA. Genomic and replicative hepatitis C virus RNA sequences and histologic activity in chronic hepatitis C Human Pathology. 25: 160-163. PMID 8119715 DOI: 10.1016/0046-8177(94)90272-0 |
0.61 |
|
| 1990 |
Dash S, Panda SK, Nayak NC. Polymerized albumin binding to serum in various liver diseases: its significance and relation to hepatitis B virus infection. Journal of Gastroenterology and Hepatology. 5: 16-24. PMID 2103380 DOI: 10.1111/J.1440-1746.1990.Tb01763.X |
0.362 |
|
| Show low-probability matches. |